Canadian Ophthalmological Society evidence-based clinical practice guidelines for cataract surgery in the adult eye;Guide de pratique clinique factuelle de la Société canadienne d'ophtalmologie pour la chirurgie de la cataracte de l'œil adulte

Canadian Journal of Ophthalmology

Volumn 43, Issue SUPPL. 1, 2008, Pages

  Bellan, Lome ^a   Ahmed, Iqbal Ike K ^b   MacInnis, Brent ^c   Mann, Colin ^d   Noël, Françoise ^e   Sanmugasunderam, Suren ^f  

^a Cataract and Oculoplastic Surgery   (Canada)

^b Cataract Surgery Glaucoma and IOL Complication Management   (Canada)

^c Comprehensive Ophthalmology ^*  (Canada)

^d Cataract Surgery ^*  (Canada)

^e NONE   (Canada)

^f Cataract Surgery   (Canada)

Author keywords

Cataract; Cataract surgery; Clinical practice guidelines; Intraocular lens

Indexed keywords

ACETAZOLAMIDE; ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; APRACLONIDINE; BENZOCAINE; BUTACAINE; CEFUROXIME; COCAINE; HYPNOTIC AGENT; LEVOFLOXACIN; LIDOCAINE; MEPIVACAINE; METHYL PARABEN; MOXIFLOXACIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PLACEBO; POVIDONE IODINE; PREDNISOLONE; PREDNISONE; PRILOCAINE; PROCAINE; SEDATIVE AGENT; SODIUM METABISULFITE; STEROID; TAMSULOSIN; TETRACAINE; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG; VANCOMYCIN;

ALLERGY; ANAPHYLAXIS; ANESTHESIA; ASTIGMATISM; BIOMETRY; BURN; CAPSULOTOMY; CATARACT; CATARACT EXTRACTION; CHOROID HEMORRHAGE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLOTHING; COMORBIDITY; CORNEA EDEMA; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DESCEMET MEMBRANE; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DIET RESTRICTION; DIPLOPIA; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG USE; DYSPHOTOPSIA; ENDOPHTHALMITIS; EVIDENCE BASED MEDICINE; EYE EXAMINATION; EYE INFLAMMATION; FIBROMA; GLAUCOMA; HOSPITAL DEPARTMENT; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE ABNORMALITY; INTRAVENOUS ANESTHESIA; INTRAVENOUS PYELOGRAPHY; IRIS DISEASE; ISCHEMIC OPTIC NEUROPATHY; KERATOPATHY; LENS CAPSULE; LENS IMPLANT; LENS LUXATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIOSIS; NEODYMIUM LASER; OPTIC NERVE DISEASE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT CARE; PERIOPERATIVE PERIOD; PHACOEMULSIFICATION; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PAIN; PRACTICE GUIDELINE; PROPHYLAXIS; PSEUDOEXFOLIATION; PTOSIS; PUPIL; REFRACTIVE SURGERY; REGIONAL ANESTHESIA; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; REVIEW; RISK MANAGEMENT; SCLEROTOMY; SEDATION; SKIN TEST; SURGICAL PATIENT; TOPICAL ANESTHESIA; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; VANCOMYCIN RESISTANT ENTEROCOCCUS; VISUAL DISORDER; VITRECTOMY; VITREOUS BODY DETACHMENT; WOUND CLOSURE; WOUND HEALING;

EID: 57449089371     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/i08-133     Document Type: Article

References (256)

1. Davis D, Goldman J, Palda VA. Handbook on Clinical Practice Guidelines. Ottawa, Ont.: Canadian Medical Association; 2007.
2. Jacobsen PD. Transforming clinical practice guidelines into legislative mandates. Proceed with abundant caution. JAMA 2007;299:208-10.
3. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82:844-51.
4. National Grouping System Categories Report, Canada 2003-2004. National Physician Database. Ottawa, Ont.: Canadian Institute for Health Information; 2005.
5. Busbee BG, Brown MM, Brown GC, et al. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology 2003;110:2310-7.
6. Javitt JC, Steinberg EP, Sharkey P, et al. Cataract surgery in one eye or both. A billion dollar per year issue. Ophthalmology 1995;102:1583-93.
7. Lundström M, Stenevi U, Thorburn W. Quality of life after first- and second-eye cataract surgery: five-year data collected by the Swedish National Cataract Register. J Cataract Refract Surg 2001;27:1553-9.
8. Naeim A, Keeler EB, Gutierrez PR, et al. Is cataract surgery cost-effective among older patients with a low predicted probability for improvement in reported visual functioning? Med Care 2006;44:982-9.
9. Obstbaum SA; American Academy of Ophthalmology; American Society of Cataract and Refractive Surgery; European Society of Cataract and Refractive Surgeons. Utilization, appropriate care, and quality of life for patients with cataracts: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, and European Society of Cataract and Refractive Surgeons. Ophthalmology 2006;113:1878-82.
10. Lansingh VC, Carter MJ, Martens M. Global cost-effectiveness of cataract surgery. Ophthalmology 2007:114;1670-8.
11. Waiting for Health Care in Canada: What We Know and What We Don't Know. Ottawa, Ont.: Canadian Institute for Health Information; 2006. Available at: http://secure.cihi.ca/cihiweb/products/WaitTimesReport_06_e.pdf. Accessed May 1, 2008.
12. Taylor HR. LXIII Edward Jackson Memorial Lecture: Eye care: dollars and sense. Am J Ophthalmol 2007;143:1-8.
13. Leinonen J, Laatikainen L. Changes in visual acuity of patients undergoing cataract surgery during the last two decades. Acta Ophthalmol Scand 2002;80:506-11.
14. Taylor HR. Cataract: how much surgery do we have to do? Br J Ophthalmol 2000;84:1-2.
15. Buhrmann R, Hodge W, Beardmore J, et al. Foundation for a Canadian Vision Health Strategy: Towards Preventing Avoidable Blindness and Promoting Vision Health. Ottawa, Ont.: National Coalition for Vision Health; 2006.
16. Canadian Diabetes Association Clinical Practice Guideline Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes 2003;27(suppl2):S1-152.
17. Feldman RD, Campbell N, Larochelle P, et al. 1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension. CMAJ 1999;161(suppl 12):S1-21.
18. AGREE Collaboration. Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument. 2001. Available at: http://www. agreecollaboration.org. Accessed July 31, 2008.
19. Bhan A, Dave D, Vernon SA, Bhan K, Bhargava J, Goodwin H; for the Medical Defence Union; Medical Protection Society; Medical and Dental Defence Union of Scotland. Risk management strategies following analysis of cataract negligence claims. Eye 2005;19:264-8.
20. The Royal College of Ophthalmologists. Cataract Surgery Guidelines. Appendix A and B. 2004:57-62. Available at: http://www.rcophth. ac.uk. Accessed July 8, 2008.
21. Kelly SP, Astbury NJ. Patient safety in cataract surgery. Eye 2006;20:275-82.
22. Mandal K, Adams W, Fraser S. "Near misses" in a cataract theatre: how do we improve understanding and documentation? Br J Ophthalmol 2005;89:1565-8.
23. Bell CM, Hatch WV, Cernat G, Urbach DR. Surgeon volumes and selected patient outcomes in cataract surgery. Ophthalmology 2007;114:405-10.
24. American Academy of Ophthalmology. Preferred Practice Pattern: Cataract in the Adult Eye. San Francisco, Calif.: American Academy of Ophthalmology; 2007. Available at: http://www.aao.org/ppp. Accessed May 1, 2008.
25. Harwood RH, Foss AJ, Osborn F, Gregson RM, Zaman A, Masud T. Falls and health status in elderly women following first eye cataract surgery: a randomized controlled trial. Br J Ophthalmol 2005;89:53-9.
26. Owsley C, McGwin G Jr, Sloane M, et al. Impact of cataract surgery on motor vehicle crash involvement by older adults. JAMA 2002;288:841-9.
27. Asplund R, Ejdervik Lindblad B. The development of sleep in persons undergoing cataract surgery. Arch Gerontol Geriatr 2002;35:179-87.
28. Asplund R, Lindblad BE. Sleep and sleepiness 1 and 9 months after cataract surgery. Arch Gerontol Geriatr 2004;38:69-7'5.
29. Tobacman JK, Zimmerman B, Lee P, Hilborne L, Kolder H, Brook RH. Visual acuity following cataract surgeries in relation to preoperative appropriateness ratings. Med Decis Making 2003;23:122-30.
30. Conner-Spady BL, Sanmugasunderam S, Courtright P, McGurran JJ, Noseworthy TW; for the Steering Committee of the Western Canada Waiting List Project. The prioritization of patients on waiting lists for cataract surgery: validation of the Western Canada waiting list project cataract priority criteria tool. Ophthalmic Epidemiol 2005;12:81-90.
31. Quintana J, Escobar A, Arostegui I. Development of appropriateness explicit criteria for cataract extraction by phacoemulsification. BMC Health Serv Res 2006;6:23.
32. Hodge W, Horsley T, Albiani D, et al. The consequences of waiting for cataract surgery: a systematic review. CMAJ 2007;176:1285-90.
33. Hatch WV, Cernat G, Singer S, Bell CM. A 10-year cohort analysis of cataract surgery rates in Ontario. Can J Ophthalmol 2007;42:552-6.
34. De Coster C, Dik N, Bellan L. Health care utilization for injury in cataract surgery patients. Can J Ophthalmol 2007;42:567-72.
35. Conner-Spady BL, Sanmugasunderam S, Courtright P, et al. Determinants of patient satisfaction with cataract surgery and length of time on the waiting list. Br J Ophthalmol 2004;88:1305-9.
36. Wait Time Alliance for Timely Access. It's About Time! Achieving Benchmarks and Best Practices in Wait Time Management. Final Report. Ottawa, Ont.: Canadian Medical Association; 2005.
37. Conner-Spady B, Sanmartin C, Sanmugasunderam S, et al. A systematic literature review of evidence towards cataract surgery waiting time benchmarks. Can J Ophthalmol 2007;42:543-51.
38. Douthwaite WA, Vianya-Estopà M, Elliott DB. Predictions of postoperative visual outcome in subjects with cataract: a preoperative and postoperative study. Br J Ophthalmol 2007;91:638-43.
39. Syam PP, Eleftheriadis H, Casswell AG, Brittain GP, McLeod BK, Liu CS. Clinical outcome following cataract surgery in very elderly patients. Eye 2004;18:59-62.
40. Muhtaseb M, Kalhoro A, Ionides A. A system for preoperative stratification of cataract patients according to risk of intraoperative complications: a prospective analysis of 1441 cases. Br J Ophthalmol 2004;88:1242-6.
41. Osborne SA, Severn P, Bunce CV, Fraser SG. The use of a preoperative scoring system for the prediction of phacoemulsification case difficulty and the selection of appropriate cases to be performed by trainees. BMC Ophthalmol 2006;6:38.
42. Bassett K, Noertjojo K, Nirmalan P, Courtright P, Anderson D. RESIO revisited: visual function assessment and cataract surgery in British Columbia. Can J Ophthalmol 2005;40:27-33.
43. Pager CK. Expectations and outcomes in cataract surgery. Arch Ophthalmol 2004;122:1788-92.
44. Pomberg ML, Miller KM. Functional visual outcomes of cataract extraction in monocular versus binocular patients. Am J Ophthalmol 2004;138:125-32.
45. Trotter WL, Miller KM. Outcomes of cataract extraction in functionally monocular patients: case-control study. J Cataract Refract Surg 2002;28:1348-54.
46. Bergwerk KL, Miller KM. Outcomes of cataract surgery in monocular patients. J Cataract Refract Surg 2000;26:1631-7.
47. Castells X, Comas M, Alonso J, et al. In a randomized controlled trial, cataract surgery in both eyes increased benefits compared to surgery in one eye only. J Clin Epidemiol 2006;59:201-7.
48. Foss AJ, Harwood RH, Osborn F, Gregson RM, Zaman A, Masud T. Falls and health status in elderly women following second eye cataract surgery: a randomized controlled trial. Age Ageing 2006;35:66-71.
49. Lundström M, Albrecht S, Nilsson M, Aström B. Benefit to patients of bilateral same-day cataract extraction: Randomized clinical study. J Cataract Refract Surg 2006;32:826-30.
50. Arshinoff SA, Strube YN, Yagev M. Simultaneous bilateral cataract surgery. J Cataract Refract Surg 2003;29:1281-91.
51. Johansson BA, Lundh BL. Bilateral same day phacoemulsification: 220 cases retrospectively reviewed. Br J Ophthalmol 2003;87:285-90.
52. Ozdek S, Onaran Z, Gurelik G, et al. Bilateral endophthalmitis after simultaneous bilateral cataract surgery. J Cataract Refract Surg 2005;31:1261-2.
53. Kashkouli MB, Salimi S, Aghaee H, Naseripour M. Bilateral Pseudomonas aeruginosa endophthalmitis following bilateral simultaneous cataract surgery. Indian J Ophthalmol 2007;55:374-5.
54. Wang JJ, Klein R, Smith W, et al. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies. Ophthalmology 2003;110:1960-7.
55. Klein R, Klein BE, Wong TY, Tomany SC, Cruikshanks KJ. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: The Beaver Dam Eye Study. Arch Ophthalmol 2002;120:1551-8.
56. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins c and e, beta carotene, and zinc for age-related macular degenerarion and vision loss: AREDS Report No. 8. Arch Ophthalmol 2001;119:1417-36.
57. Velez G, Weiter JJ. Cataract extraction and age-related macular degeneration: associations, diagnosis and management. Semin Ophthalmol 2002;17:187-95.
58. Pham TQ Wang JJ, Maloof A, Mitchell P. Cataract surgery in patients with age-related maculopathy: preoperative diagnosis and postoperative visual acuity. Clin Experiment Ophthalmol 2005;33:360-3.
59. Seitzman GD, Gottsch JD, Stark WJ. Cataract surgery in patients with Fuchs corneal dystrophy: expanding recommendations for cataract surgery without simultaneous keratoplasty. Ophthalmology 2005;112:441-6.
60. Verges C, Cazal J, Lavin C. Surgical strategies in patients with cataract and glaucoma. Curr Opin Ophthalmol 2005;16:44-52.
61. Hylton C, Congdon N, Friedman D, et al. Cataract after glaucoma filtration surgery. Am J Ophthalmol 2003;135:231-2.
62. Crichton AC, Kirker AW. Intraocular pressure and medication control after clear corneal phacoemulsification and AcrySof posterior chamber intraocular lens implantation in patients with filtering blebs. J Glaucoma 2001;10:38-46.
63. Heltzer JM. Coexisting glaucoma and cataract [comment]. Ophthalmology 2004;111:408-9.
64. Lahey JM, Francis RR, Kearney JJ. Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy: a series of 223 cases. Ophthalmology 2003;110:1335-9.
65. Lahey JM, Francis RR, Kearney JJ, Cheung M. Combining phacoemulsification and vitrectomy in patients with proliferative diabetic retinopathy. Curr Opin Ophthalmol 2004;15:192-6.
66. Murtha T, Cavallerano J. The management of diabetic eye disease in the setting of cataract surgery. Curr Opin Ophthalmol 2007;18:13-8.
67. Mittra RA, Borillo JL, Dev S, Mieler WF, Konig SB. Retinopathy progression and visual outcomes after phacoemsulsification in patients with diabetes mellitus. Arch Ophthalmol 2000;118:912-7.
68. Antcliff RJ, Poulson A, Flanagan DW. Phacoemulsification in diabetics. Eye 1996;10:737-41.
69. Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. Philadelphia, Pa.: WB Saunders Company; 2002.
70. Foster CS, Rashid S. Management of coincident cataract and uveitis. Curr Opin Ophthalmol 2003;14:1-6.
71. Drolsum L. Long-term follow-up after deep sclerectomy in patients with pseudoexfoliative glaucoma. Acta Ophthalmol Scand 2006;84:502-6.
72. Drolsum L, Ringvold A, Nicolaissen B. Cataract and glaucoma surgery in Pseudoexfoliation syndrome: a review. Acta Ophthalmol Scand 2007;85:810-21.
73. Küchle M, Viestenz A, Martus P, Händel A, Jünemann A, Naumann GO. Anterior chamber depth and complications during cataract surgery in eyes with pseudoexfoliation syndrome. Am J Ophthalmol 2000;129:281-5.
74. Bayraktar S, Altan T, Küçüksümet Y, Yilmaz OF. Capsular tension ring implantation after capsulorhexis in phacoemulsification of cataracts associated with pseudoexfoliation syndrome. Intraoperative complications and early postoperative findings. J Cataract Refract Surg 2001;27:1620-8.
75. Braunstein RE, Airiani S. Cataract surgery results after pars plana vitrectomy. Curr Opin Ophthalmol 2003;14:150-4.
76. Chang MA, Parides MK, Chang S, Braunstein RE. Outcome of phacoemulsification after pars plana vitrectomy. Ophthalmology 2002;109:948-54.
77. Chaudhry NA, Cohen KA, Flynn HW Jr, Murray TG. Combined pars plana vitrectomy and lens management in complex vitreoretinal disease. Semin Ophthalmol 2003;18:132-41.
78. Reeves SW, Tielsch JM, Katz J, Bass EB, Schein OD. A self-administered health questionnaire for the preoperative risk stratification of patients undergoing cataract surgery. Am J Ophthalmol 2003;135:599-606.
79. Schein OD, Katz J, Bass EB, et al. The value of routine preoperative medical testing before cataract surgery. N Engl J Med 2000;342:168-75.
80. Cheung D, Gillow T. Cataract surgery for natural rubber latex allergic patients. Eye 2003;17:129-38.
81. Cataract surgery for natural rubber latex allergic patients [correspondence]. Eye 2004;18:845-6.
82. Coakley FV, Panicek DM. Iodine allergy: an oyster without a pearl? AJR Am J Roentgenol 1997;169:951-2.
83. Coia JE. Guidelines for the control and prevention of MRSA in healthcare facilities. J Hosp Infect 2007;63S:S1-44.
84. Falk PS. How can VRE infections be prevented in surgery? Infection Control Today. Available at : http://www.infectioncontroltoday.com/articles/ 071feat3.html. Accessed May 14, 2008.
85. Stoller GL. Ophthalmic surgery and the implantable cardioverter defibrillator. Arch Ophthalmol 2006;124:123-5.
86. Canadian Anesthesiologists' Society. Guidelines to the Practice of Anesthesia. Can J Anesth 2006;53(suppl):1-38.
87. Morris EA, Mather SJ. A survey of pre-operative fasting regimens before regional ophthalmic anaesthesia in three regions of the United Kingdom. Anaesthesia 2001; 56:1005-6.
88. Katz J, Feldman MA, Bass EB, et al; for the Study of Medical Testing for Cataract Surgery Study Team. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 2003;110:1784-8.
89. Benzimra JD, Johnson RL, Jaycock P, et al. The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications. Eye 2008 Feb 8 (Epub ahead of print).
90. Greco RJ, Gonzalez R, Johnson P Scolieri M, Rekhopf G, Heckler F. Potential dangers of oxygen supplementation during facial surgery. Plastic Reconstr Surg 1995;95:978-84.
91. Barnes AM, Frantz RA. Do oxygen-enriched atmospheres exist beneath surgical drapes and contribute to fire hazard potential in the operating room? AANA J 2000;68:153-61.
92. Chang DF, Campbell JR. Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg 2005;31:664-73.
93. Lu DP. Managing patients with local anesthetic complications using alternative methods. Pa Dent J 2002;69:22-9.
94. Drance D, Basti S, Koch, D. Use of preservative-free lidocaine for cataract surgery in a patient allergic to "caines". J Cataract Refract Surg 2005;31:848-50.
95. Eggleston ST, Lush LW. Understanding allergic reactions to local anesthetics. Ann Pharmacother 1996;30:851-7.
96. Operating Room Nurses Association of Canada. Infection control. In: Recommended Standards, Guidelines and Position Statements for Perioperative Registered Nursing Practice. 7th ed. 2006:25.
97. Rocha G, Turner C. Safety of cataract surgery under topical anesthesia with oral sedation without anesthetic monitoring. Can J Ophthalmol 2007;42:288-94.
98. Zakrzewski PA, Friel T, Fox G, et al. Monitored anesthesia care provided by registered respiratory care practitioners during cataract surgery. A report of 1957 cases. Ophthalmology 2005;112:272-7.
99. Tantri A, Clark C, Huber P, et al. Anesthesia monitoring by registered nurses during cataract surgery: Assessment of need for intraoperative anesthesia consultation. J Cataract Refract Surg 2006;32:1115-8.
100. Pandey SK, Werner L, Apple DJ, Agarwal A, Agarwal A, Agarwal S. No-anesthesia clear corneal phacoemulsification versus topical and topical plus intracameral anesthesia. Randomized clinical trial. J Cataract Refract Surg 2001;27:1643-50.
101. Henry C, Navarro V, Jun A, Annaberdyev S. Measuring the "fifth vital sign" in cataract surgery patients - is it necessary? Insight 2006;31:7-9.
102. Katz J, Feldman MA, Bass EB, et al; for the Study of Medical Testing for Cataract Surgery Study Team. Adverse intraoperative medical events and their association with anesthesia management strategies in cataract surgery. Ophthalmology 2001;108:1721-6.
103. Friedman DS, Reeves SW, Bass EB, et al. Patient preferences for anaesthesia management during cataract surgery. Br J Ophthalmol 2004;88:333-5.
104. Anesthesia Management During Cataract Surgery. Rockville, Md.: Agency for Healthcare Research and Quality; 2000. AHRQ Publication No. 00-E015. Available at: http://www.ahrq.gov/clinic/epcsums/anestsum.htm. Accessed May 1, 2008.
105. Ezra D, Allan B. Topical anaesthesia alone versus topical anaesthesia with intracameral lidocaine for phacoemulsification. Cochrane Database Syst Rev 2007;18(3):CD005276.
106. Boulton JE, Lopatatzidis A, Luck J, Baer RM. A randomized controlled trial of intracameral lidocaine during phacoemulsification under topical anesthesia. Ophthalmology 2000;107:68-71.
107. Heuermann T, Hartmann C, Anders N. Long-term endothelial cell loss after phacoemulsification: Peribulbar anesthesia versus intracameral lidocaine 1%. Prospective randomized clinical trial. J Cataract Refract Surg 2002;28:639-43.
108. Kim T, Holley GP, Lee JH, et al. The effects of intraocular lidocaine on the corneal endothelium. Ophthalmology 1998;105:125-30.
109. Anderson NJ, Woods WD, Kim T, Rudnick DE, Edelhauser HF. Intracameral anesthesia: in vitro iris and corneal uptake and washout of 1% lidocaine hydrochloride. Arch Ophthalmol 1999;117:225-32.
110. Schelenz J, Kammann J. Comparison of contact and immersion techniques for axial length measurement and implant power calculation. J Cataract Refract Surg 1989;15:425-8.
111. Packer M, Fine IH, Hofftnan RS, Coffmann PG, Brown LK. Immersion A-scan compared with partial coherence interferometry: outcome analysis. J Cataract Refract Surg 2002; 28:239-42.
112. Lege BA, Haigis W. Laser interference biometry versus ultrasound biometry in certain clinical conditions. Graefes Arch Clin Exp Ophthalmol 2004;242:8-12.
113. Dietlein TS, Roessler G, Lüke C, et al. Signal quality of biometry in silicone oil-filled eyes using partial coherence laser interferometry. J Cataract Refract Surg 2005;31:1006-10.
114. Tehrani M, Krummenauer F, Blom E, Dick HB. Evaluation of the practicality of optical biometry and applanation ultrasound in 253 eyes. J Cataract Refract Surg 2003;29:741-6.
115. Holladay JT. Standardizing constants for ultrasonic biometry, keratometry, and intraocular lens power calculations. J Cataract Refract Surg 1997;23:1356-70.
116. Hoffer KJ. The Hoffer Q formula: a comparison of theoretic and regression fotmulas. J Cataract Refract Surg 1993;19:700-12.
117. Narváez J, Zimmerman G, Smiting RD, Chang DH. Accuracy of intraocular lens power prediction using the Hoffer Q, Holladay 1, Holladay 2, and SRK/T formulas. J Cataract Refract Surg 2006;32:2050-3.
118. Hoffer KJ. Clinical results using the Holladay 2 intraocular lens power formula. J Cataract Refract Surg 2000;26:1233-7.
119. Haigis W, Lege B, Miller N, Schneider B. Comparison of immersion ultrasound biometry and partial coherence interferometry for intraocular lens calculation according to Haigis. Graefes Arch Clin Exp Ophthalmol 2000;238:765-73.
120. MacLaren RE, Natkunarajah M, Riaz Y, Bourne RR, Restori M, Allan BD. Biometry and formula accuracy with intraocular lenses used for cataract surgery in extreme hyperopia. Am J Ophthalmol 2007;143:920-31.
121. Wang L, Booth MA, Koch DD. Comparison of intraocular lens power calculation methods in eyes that have undergone LASIK. Ophthalmology 2004;111:1825-31.
122. Masket S, Masket SE. Simple regression formula for intraocular lens power adjustment in eyes requiring cataract surgery after excimer laser photoablation. J Cataract Refract Surg 2006;32:430-4.
123. Feiz V, Moshirfar M, Mannis MJ, et al. Nomogram-based intraocular lens power adjustment after myopic photorefractive keratectomy and LASIK: a new approach. Ophthalmology 2005;112:1381-7.
124. Rosa N, Capasso L, Lanza M, Iaccarino M, Romano A. Reliability of a new correcting factor in calculating intraocular lens power after refractive corneal surgery. J Cataract Refract Surg 2005;31:1020-4.
125. Walter KA, Gagnon MR, Hoopes PC Jr, Dickinson PJ. Accurate intraocular lens power calculation after myopic laser in situ keratomileusis, bypassing corneal power. J Cataract Refract Surg 2006;32:425-9.
126. Borasio, Stevens J, Smith GT. Estimation of true corneal power after keratorefractive surgery in eyes requiring cataract surgery: BESSt formula. J Cataract Refract Surg 2006;32:2004-14.
127. Aramberri J. Intraocular lens power calculation after corneal refractive surgery: double-K method. J Cataract Refract Surg 2003;29:2063-8.
128. Gimbel HV, DeBroff BM. Intraocular lens optic capture. J Cataract Refract Surg 2004;30:200-6.
129. LeBoyer RM, Werner L, Snyder ME, Mamalis N, Riemann CD, Augsberger JJ. Acute hepatic-induced ciliary sulcus irritation associated with single-piece AcrySof intraocular lenses. J Cataract Refract Surg 2005;31:1421-7.
130. Wagoner MD, Cox TA, Ariyasu RG, et al. Intraocular lens implantation in the absence of capsular support. A report by the Ametican Academy of Ophthalmology. Ophthalmology 2003;110:840-59.
131. Goldsmith JA, Li Y, Chalita MR, et al. Anterior chamber width measurement by high-speed optical coherence tomography. Ophthalmology 2005;112:238-44.
132. Oshika T, Nagahara K, Yaguchi S, et al. Three year prospective, fandomized evaluation of intraocular lens implantation through 3.2 and 5.5 mm incisions. J Cataract Refract Surg 1998;24:509-14.
133. Meacock WR, Spalton DJ, Boyce JF, Jose JR. Effect of optic size on posterior capsular opacification: 5.5 mm versus 6.0 mm optic diameter Acrysof intraocular lenses. J Cataract Refract Surg 2001;27:1194-8.
134. Abela-Formanek C, Anion M, Schild G, Schauersberger J, Heinze G, Kruger A. Uveal and capsular biocompatibility of hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses. J Cataract Refract Surg 2002;28:50-61.
135. Mayer E, Cadman D, Ewings P, et al. A 10-year retrospective study of cataract surgery and endophthalmitis in a single unit; injectable lenses lower the incidence of endophthalmitis. Br J Ophthalmol 2003;87:867-9.
136. Braunstein RE, Sparrow JR. A blue-blocking intraocular lens should be used in cataract surgery. Arch Ophthalmol 2005;123:547-9.
137. Mainster MA. Intraocular lenses should block UV radiation and violet but not blue light. Arch Ophthalmol 2005;123:550-5.
138. Packer M, Fine IH, Hoffmans RS, Piers PA. Improved functional vision with a modified prolate intraocular lens. J Cataract Refract Surg 2004;30:986-92.
139. Beiko G. Personalized correction of spherical aberration in cataract surgery. J Cataract Refract Surg 2007;33:1455-60.
140. Wang L, Koch DD. Effect of decentration on wavefront-corrected intraocular lens on the higher-order aberrations of the eye. Arch Ophthalmol 2005;123:1226-30.
141. Kohnen T, Mahmoud K, Burhren J. Comparison of corneal higher-order aberration induced by myopic and hyperopic LASIK. Ophthalmology 2005;112:1692.
142. Horn JD. Status of toric intraocular lenses. Curr Opin Ophthalmol 2007;18:58-61.
143. Weinand F, Jung A, Stein A, Pfützner A, Becker R, Pavlovic S. Rotational stability of a single-piece hydrophobic acrylic lens: new method for high-precision rotation control. J Cataract Refract Surg 2007;33:800-3.
144. Leyland M, Zinicola E. Multifocal versus monofocal intraocular lenses in cataract surgery: a systematic review. Ophthalmology 2003;110:1789-8.
145. Cumming JS, Colvard DM, Dell SJ, et al. Clinical evaluation of the crystalens AT-45 accommodating intraocular lens. Results of the U.S. Food and Drug Administration clinical trial. J Cataract Refract Surg 2006;32:812-25.
146. Greenbaum S. Monovision pseudophakia. J Cataract Refract Surg 2002;28:1439-43.
147. Minassian DC, Rosen P, Dart JK, et al. Extracapsular cataract extraction compared with small incision surgery by phacoemulsification: a randomized trial. Br J Ophthalmol 2001;85:822-9.
148. Tsorbatzoglou A, Modis L, Kertesz K, Németh G, Berta A. Comparison of divide and conquer and phaco-chop techniques duting fluid-based phacoemulsification. Eur J Ophthalmol 2007;17:315-9.
149. Masket S, Nichamin LD, Chang DF, Johnson SH, et al; for the American Society of Cataract and Refractive Surgery Cataract Clinical Committee. ASCRS White Paper: What is the association between clear corneal cataract incisions and postoperative endophthalmitis? 2006;32:1556-9.
150. Hayashi K, Hayashi H, Nakao F, Hayashi F. The correlation between incision size and corneal shape changes in sutureless cataract surgery. Ophthalmology 1995;102:550-6.
151. Gimbel HV, Neuhann T. Development, advantages, and methods of the continous circular capsulorhexis technique. J Cataract Refract Surg 1990;16:31-7.
152. Hollick EJ, Spalton DJ, Meacock WR. The effect of capsulorhexis size on posterior capsular opacification: one-year results of a randomized prospective trial. Am J Ophthalmol 1999;128:271-9.
153. Vasavada AR, Dholakia SA, Raj RM, Singh R. Effect of cortical cleaving hydrodissection on posterior capsule opacification in age-related nuclear cataract. J Cataract Refract Surg 2006;32:1196-200.
154. Goldman JM, Karp CL. Adjunct devices for managing challenging cases in cataract surgery: capsular staining and ophthalmic viscosurgical devices. Curr Opin Ophthalmol 2007;18:52-7.
155. Jacobs DS, Cox TA, Wagoner MD, Ariyasu RG, Karp CL. American Academy of Ophthalmology. Ophthalmic Technology Assessment Committee Anterior Segment Panel. Capsule staining as an adjunct to cataract surgery: a report from the American Academy of Ophrhalmology. Ophthalmology 2006;113:707-13.
156. Hasanee K, Ahmed IK. Capsular tension rings: Update on endocapsular support devices. Ophthalmol Clin North Am 2006;19:507-19.
157. Lee DH, Shin SC, Joo CK. Effect of a capsular tension ring on intraocular lens decentration and tilting after cataract surgery. J Cataract Refract Surg 2002;28:843-6.
158. Ahmed IK, Chen SH, Kranemann C, et al. Surgical repositioning of dislocated capsular tension rings. Ophthalmology 2005;112:1725-33.
159. Goldman JM, Karp CL. Adjunct devices for managing challenging cases in cataract surgery: pupil expansion and stabilization of the capsular bag. Curr Opin Ophthalmol 2007;18:44-51.
160. Akman A, Yilmaz G, Oto S, Akova YA. Comparison of various pupil dilatation methods for phacoemulsification in eyes with a small pupil secondary to Pseudoexfoliation. Ophthalmology 2004;111:1693-8.
161. Chang DF, Osher RH, Wang L, Koch DD. Prospective multicenter evaluation of cataract surgery in patients taking tamsulosin (Flomax). Ophthalmology 2007;114:957-64.
162. Chan FM, Mathur R, Ku JJ, et al. Short-term outcomes in eyes with posterior capsule rupture during cataract surgery. J Cataract Refract Surg 2003;29:537-41.
163. Arbisser LB, Charles S, Howcroft M, Werner L. Management of vitreous loss and dropped nucleus during cataract surgery. Ophthalmol Clin North Am 2006;19:495-506.
164. Kim IK, Miller JW. Management of dislocated lens material. Semin Ophthalmol 2002;17:162-6.
165. Yang CS, Lee FL, Hsu WM, Liu JH. Management of retained intravitreal lens fragments after phacoemulsification surgery. Ophthalmologica 2002;216:192-7.
166. Salam GA, Greene JM, Deramo VA, et al. Retinal tears and retinal detachment as factors affecting visual outcome after cataract extraction complicated by posteriorly dislocated lens material. Retina 2005;25:570-5.
167. Paganelli F, Cardillo JA, Melo LA Jr, Oliveira AG, Skaf M, Costa RA; Brazilian Ocular Pharmacology and Pharmaceutical Technology Research Group. A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation. Ophthalmology 2004;111:2102-8.
168. Meacock WR, Spalton DJ, Bender L, et al. Steroid prophylaxis in eyes with uveitis undergoing phacoemulsification. Br J Ophthalmol 2004;88:1122-4.
169. Chang DF, Stulting RD, Thomas EL, et al. Advances in surgical anti-inflammatory pharmacology. Ophthalmology Times 2007;32(suppl4):1-12.
170. Donnenfeld ED, Perry HD, Wittpenn JR, Solomon R, Nattis A, Chou T. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg 2006;32:1474-82.
171. O'Brien TP. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. Curr Med Res Opin 2005;21:1131-7.
172. Yavas GF, Oztürk F, Küsbeci T. Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. J Cataract Refract Surg 2007;33:804-7.
173. Ray S, D'Amico DJ. Pseudophakic cystoid macular edema. Semin Ophthalmol 2002;17:167-80.
174. Nelson ML, Martidis A. Managing cystoid macular edema after cataract surgery. Curr Opin Ophthalmol 2003;14:39-43.
175. Gulkilik G, Kocabora S, Taskapili M, Engin G. Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity. Can J Ophthalmol 2006;41:699-703.
176. Sivaprasad S, Bunce C, Patel N. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev 2005: CD004239.
177. Rossetti L, Chaudhuri J, Dickersin K. Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis. Ophthalmobgy 1998;105:397-405.
178. Wang RC, Lou PL, Ryan EA, et al. Antibiotic therapy in postoperative endophthalmitis. Semin Ophthalmol 2002; 17:153-61.
179. Taban M, Behrens A, Newcomb RL, et al. Acute endophthalmitis following cataract surgery, a systematic review of the literature. Arch Ophthalmol 2005;123:613-20.
180. Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991;98:639-49.
181. Ng JQ Morlet N, Bulsara MK, Semmens JB. Reducing the risk for endophdialmitis after cataract surgery: population-based nested case-control study: endophdialmitis population study of Western Australia sixth report. J Cataract Refract Surg 2007;33:269-80.
182. Wong TY, Chee SP. The epidemiology of acute endophthalmitis after cataract surgery in an Asian population. Ophthalmology 2004;111:699-705.
183. Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 2005;139:983-7.
184. Lundström M, Wejde G, Stenevi U, Thorburn W, Montan P. Endophthalmitis after cataract surgery, A nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology 2007;114:866-70.
185. Li J, Morlet N, Ng JQ, Semmens JB, Knuiman MW; for Team EPSWA. Significant nonsurgical risk factors fot endophthalmitis after cataract surgery: EPSWA fourth report. Invest Ophthalmol Vis Sci 2004;45:1321-8.
186. Sobaci G, Tuncer K, Tas A, Ozyurt M, Bayer A, Kutlu U. The effect of intraoperative antibiotics in irrigating solutions on aqueous humor contamination and endophthalmitis after phacoemulsification surgery. Eur J Ophthalmol 2003;13:773-8.
187. Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of
188. Seal DV, Barry P, Gettinby G, et al; ESCRS Endophthalmitis Study Group. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study. J Cataract Refract Surg 2006;32:396-406.
189. Barry P, Seal DV, Gettinby G, Lees F, Peteson M, Review CW; for the ESCRS Endophthalmitis Study Group. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study. J Cataract Refract Surg 2006;32:407-10.
190. Montan PG, Wejde G, Setterquist H, Rylander M, Zetterström C. Prophylactic intracameral cefuroxime, evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg 2002;28:982-7.
191. Montan PG, Wejde G, Koranyi G, et al. Prophylactic intracameral cefuroxime, efficacy in preventing endophthalmitis aftet cataract surgery. J Cataract Refract Surg 2002;28:977-81.
192. Gupta MS, McKee HDR, Saldaña M, et al. Macular thickness after cataract surgery with intracameral cefiiroxime. J Cataract Refract Surg 2005;31:1163-6.
193. Villada JR, Vicente U, Javaloy J, et al. Severe anaphylactic reaction after intracameral antibiotic administration during cataract surgery. J Cataract Refract Surg 2005;31:620-1.
194. Mendivil SO, Mendivil MP. The effect of topical povidone-iodine, intraocular vancomycin, or both on aqueous humor cultures at the time of cataract surgery. Am J Ophthalmol 2001;131:293-300.
195. Murphy CC, Nicholson S, Quah SA, Batterbuty M, Neal T, Kaye SB. Pharmacokinetics of vancomycin following bolus injection in patients undergoing phacoemulsification cataract surgery. Br J Ophthalmol 2007;91:1350-3.
196. Espiritu CR, Caparas VL, Bolinao JG. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. J Cataract Refract Surg 2007;33:63-8.
197. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 1991;98:1769-75.
198. Ripandelli G, Coppé AM, Parisi V, et al. Posterior vitreous detachment and retinal detachment after cataract surgery. Ophthalmology 2007;114:692-7.
199. Mamalis N, Edelhauser HF, Dawson DG, et al. Toxic anterior segment syndrome. J Cataract Refract Surg 2006;32:324-33.
200. Holland SP, Morck DW, Lee TL. Update on toxic anterior segment syndrome. Curr Opin Ophthalmol 2007;18:4-8.
201. Unal M, Yucel I, Akar Y, Onar A, Amtin M. Outbreak of toxic anterior segment syndrome associated with glutaraldehyde after cataract surgery. J Cataract Refract Surg 2006;32:1696-701.
202. Leslie T, Aitken DA, Barrie T, Kirkness CM. Residual debris as a potential cause of postphacoemulsification endophthalmitis. Eye 2003;17:506-12.
203. Dinakaran S, Kayarkar VV. Debris on processed ophthalmic instruments: a cause for concern. Eye 2002;16:281-4.
204. Hellinger WC, Bacalis LP, Edelhauser HF, et al; for the ASCRS Ad Hoc Task Force on Cleaning and Sterilization of Intraocular Instruments. Recommended practices for cleaning and sterilizing intraocular surgical instruments. J Cataract Refract Surg 2007;33:1095-100.
205. Yi DH, Dana MR. Corneal edema after cataract surgery: incidence and etiology. Semin Ophthalmol 2002;17:110-4.
206. Irving EL, Arshinoff SA, Samis W, et al. Effect of retrobulbar injection of lidocaine on saccadic velocities. J Cataract Refract Surg 2004;30:350-6.
207. Lee MS, Rizzo JF III, Lessell S. Neuro-ophthalmologic complications of cataract surgery. Semin Ophthalmol 2002;17:149-52.
208. Bernardino CR, Rubin PA. Ptosis after cataract surgery. Semin Ophthalmol 2002;17:144-8.
209. Nouri M, Pineda R Jr, Azar D. Descemet membrane tear after cataract surgery. Semin Ophthalmol 2002;17:115-9.
210. Marcon AS, Rapuano CJ, Jones MR, Laibson PR, Cohen EJ. Descemet's membrane detachment after cataract surgery: management and outcome. Ophthalmology 2002;109:2325-30.
211. Borasio E, Mehta JS, Maurino V. Surgically induced astigmatism after phacoemulsification in eyes with mild to moderate corneal astigmatism: temporal versus on-axis clear corneal incisions. J Cataract Refract Surg 2006;32:565-72.
212. Borasio E, Maurino V, Nambiar AK. Site for incision for sutureless cataract surgery (phacoemulsification) and surgically induced astigmatism (protocol). Cochrane Database Syst Rev 2005(2):CD005260.
213. Ozkurt Y, Oral Y, Karacan O, Comez A, Dogan OK. Comparison of the effects of dorzolamide-timolol fixed combination and brimonidine on intraocular pressure after phacoemulsification surgery. Eye Contact Lens 2008;34:21-3.
214. Arshinoff S. Postoperative intraocular pressure spikes. J Cataract Refract Surg 2004;30:733-4.
215. Fry LL. Comparison of the post-opetative intraocular pressure with betagan, betoptic, timoptic, iopidine, diamox, pilopine gel, and miostat. J Cataract Refract Surg 1992;18:14-19.
216. Zamvar U, Dhillon B. Postoperative IOP prophylaxis practice following uncomplicated cataract surgery: a UK-wide consultant survey. BMC Ophthalmol 2005;5:24.
217. Scuderi G, Regine F, Perdicchi A, et al. Comparative efficacy of acetazolamide and apraclonidine in the control of intraocular pressure following phacoemulsification. Ophthalmologica 2006;220:356-60.
218. Chu TG, Green RL. Surprachoroidal hemorrhage. Surv Ophthalmol 1999;43:471-86.
219. Ling R, Cole M, James C, Kamalarajah S, Shaw S. Suprachoroidal haemorrhage complicating cataract surgery in the UK a case control study of risk factors. Br J Ophthalmol 2004;88:474-7.
220. Ling R, Cole M, James C, Kamalarajah S, Foot B, Shaw S. Suprachoroidal haemorrhage complicating cataract surgery in the UK: epidemiology, clinical features, management, and outcomes. Br J Ophthalmol 2004;88:478-80.
221. Basti S, Hu DJ, Goren MB, Tanna AP. Acute suprachoroidal hemorrhage during clear corneal phacoemulsification using topical and intracameral anesthesia. J Cataract Refract Surg 2003;29:588-91.
222. Tinley CG, Frost A, Hakin KN, et al. Is visual outcome compromised when next day review is omitted after phacoemulsification surgery? A randomized control trial. Br J Ophthalmol 2003;87:1350-5.
223. Alwitry A, Rotchford A, Gardner I. First day review after uncomplicated phacoemulsification: is it necessary? Eur J Ophthalmol 2006;16:554-9.
224. Tan JH, Newman DK, Klunker C, Watts SE, Burton RL. Phacoemulsifaction cataract surgery: is routine review necessary on the first post-operative day? Eye 2000;14:53-5.
225. Saeed A, Guerin M, Khan I, et al. Deferral of first review after uneventful phacoemulsification cataract surgery until 2 weeks: randomized controlled study. J Cataract Refract Surg 2007;33:1591-6.
226. Ahmed II, Kranemann C, Chipman M, Malam F. Revisiting early postoperative follow-up after phacoemulsification. J Cataract Refract Surg 2002;28:100-8.
227. Mandal K, Dodds S, Hildreth A, et al. Comparative study of first-day postoperative cataract review methods. J Cataract Refract Surg 2004;30:1966-71.
228. Thirumalai B, Blamires T, Brooker L, et al. Heavier molecular weight ocular viscoelastic devices and timing of post-operative review following cataract surgery. BMC Ophthalmology 2007;7:2.
229. Sugar A, Sadri E, Dawson DG, Musch DC. Refractive stabilization after temporal phacoemulsification with foldable acrylic intraocular lens implantation. J Cataract Refract Surg 2001;27:1741-5.
230. Dewey S. Posterior capsule opacification. Curr Opin Ophthalmol 2006;17:45-53.
231. Cheng J, Wei R, Cai J, et al. Efficacy of different intraocular lens materials and optic edge designs in preventing posterior capsular opacification: A meta-analysis. Am J Ophthalmol 2007;143:428-36.
232. Wren S, Spalton D, Jose R, et al. Factors that influence the development of posterior capsule opacification with a polyacrylic lens. Am J Ophthalmol 2005;139:691-5.
233. Findl O, Buehl W, Menapace R, Sacu S, Georgopoulos M, Rainer G. Long-term effect of sharp optic edges of a polymethyl methacrylate intraocular lens on posterior capsule opacification. Ophthalmology 2005;112:2004-8.
234. Heatley CJ, Spalton DJ, Kumar A, Jose R, Boyce J, Bender LE. Comparison of posterior capsule opacification rates between hydrophilic and hydrophobic single-piece acrylic intraocular lenses. J Cataract Refract Surg 2005;31:718-24.
235. Apple DJ, Peng Q, Visessook N, et al. Eradication of posterior capsule opacification: documentation of a marked decrease in Nd:YAG laser posterior capsulotomy rates noted in an analysis of 5416 pseudophakic human eyes obtained postmortem. Ophthalmology 2001;108:505-18.
236. Sacu S, Menapace R, Findl O, Kiss B, Buehl W, Georgopoulos M. Long-term efficacy of adding a sharp posterior optic edge to a three-piece silicone intraocular lens on capsule opacification: five-year results of a randomized study. Am J Ophthalmol 2005;138:696-703.
237. Aslam TM, Devlin H, Dhillon B. Use of Nd:YAG laser capsulotomy. Surv Ophthalmol 2003;48:594-612.
238. Tuft SJ, Minassian D, Sullivan P. Risk factors for retinal detachment after cataract surgery: a case-control study. Ophthalmology 2006;113:650-6.
239. Erie JC, Raecker BA, Baratz KH, Schleck CD, Robertson DM. Risk of retinal detachment after cataract extraction, 1980-2004: a population-based study. Trans Am Ophthalmol Soc 2006;104:167-75.
240. Gimbel HV, Condon GP, Kohnen T, Olson RJ, Halkiadakis I. Late in-the-bag intraocular lens dislocation: Incidence, prevention, and management. J Cataract Refract Surg 2005;31:2193-204.
241. Ramos M, Kruger EF, Lashkari K. Biostatistical analysis of pseudophakic and aphakic retinal detachments. Semin Ophthalmol 2002;17:206-13.
242. Lois N, Wong D. Pseudophakic retinal detachment. Surv Ophthalmol 2003;48:467-87.
243. Powe NR, Schein OD, Gieser SC, Tielsch JM, Luthra R, Javitt J, et al. Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Arch Ophthalmol 1994;112:239-52.
244. Bournas P, Drazinos S, Kanellas D, Arvantis M, Vaikoussis E. Dysphotopsia after cataract surgery: comparison of four different intraocular lenses. Ophthalmologica 2007;221:378-83.
245. Aslam T, Gupta M, Gilmour D, Patton N, Dhillon B. Long-term prevalence of pseudophakic photic phenomena. Am J Ophthalmol 2007;143:522-4.
246. Tester R, Pace N, Samore M, Olson R. Dysphotopsia in phakic and pseudophakic patients: incidence and relation to intraocular lens type. J Cataract Refract Surg 2000;26:810-16.
247. Shambhu S, Shanmuganathan V, Charles S. The effect of lens design on dysphotopsia in different acrylic IOLs. Eye 2005;19:567-70.
248. Davison J. Positive and negative dysphotopsia in patients with acrylic intraocular lenses. J Cataract Refract Surg 2000;26:1346-55.
249. Meacock W, Spalton D, Khan S. The effect of texturing the intraocular lens edge on postoperative glare symptoms: a randomized, prospective, double-masked study. Arch Ophthalmol 2002;120:1294-8.
250. Aslam T, Dhillon B. Principles of pseudophakic photic phenomena. Ophthalmologica 2004;218:4-13.
251. Schwiegerling J. Recent developments in pseudophakic dysphotopsia. Curr Opin Ophthalmol 2006;17:27-30.
252. Wallin T, Hinckley M, Nilson C, Olson R. A clinical comparison of single-piece and three-piece truncated hydrophobic acrylic intraocular lenses. Am J Ophthalmol 2003;136:614-9.
253. Erie J, Bandhauer M, McLaren J. Analysis of postoperative glare and intraocular lens design. J Cataract Refract Surg 2001;27:614-21.
254. Erie J, Bandhauer M. Intraocular lens surfaces and their relationship to postoperative glare. J Cataract Refract Surg 2003;29:336-41.
255. Trattler W, Whitsett J, Simone P. Negative dysphotopsia after intraocular lens implantation irrespective of design and material. J Cataract Refract Surg 2005;31:841-5.
256. Ernest P. Severe photic phenomenon. J Cataract Refract Surg 2006;32:685-6.